TP53 and leukemia: The authors reported increased cytotoxicity, apoptosis, autophagic cell death and cell cycle arrest, as well as p53 upregulation and PI3K/Akt/mTOR pathway inhibition in the in vitro leukemia models and cell sampled from patients [108].